NR1H4 and Hepatic steatosis: On the other hand, our previous study has reported that TMAO could modulate bile acid metabolism and suppress bile acids-mediated hepatic nuclear receptor farnesoid X receptor (FXR) signaling to aggravate hepatic steatosis [53].